Article, Early Access,
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
Affiliations
- [1] Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Dept Cardiovasc Med, Cleveland Clin, Cleveland, OH USA [NORA names: United States; America, North; OECD];
- [2] Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Dept Cardiovasc Med, Cleveland Clin, Cleveland, OH USA [NORA names: United States; America, North; OECD];
- [3] NOVO Nordisk, Soborg, Denmark [NORA names: Novo Nordisk; Private Research; Denmark; Europe, EU; Nordic; OECD];
- [4] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh, Scotland [NORA names: United Kingdom; Europe, Non-EU; OECD];
- [5] UCL, Natl Inst Cardiovasc Outcomes Res, London, England [NORA names: United Kingdom; Europe, Non-EU; OECD];
(... more)
Abstract
Abstract not displayed. As this article is not marked as Open Access, it is unclear if we are allowed to show the abstract. Please use the link in the sidebar to view the data provider version of the article including abstract.